Spruce Biosciences Inc (SPRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 0 | 0 | 0 | 697 | 602 |
| Gross Profit | N/A | N/A | N/A | 697 | 602 |
| Operating Expenses | 8,229 | 2,692 | 14,492 | 24,771 | 10,010 |
| Operating Income | -8,229 | -2,692 | -14,492 | -24,074 | -9,408 |
| Interest Expense | 19 | 29 | 36 | 56 | 71 |
| Other Income | 36 | 654 | 487 | 571 | 808 |
| Pre-tax Income | -8,212 | -2,067 | -14,041 | -23,559 | -8,671 |
| Net Income Continuous | -8,212 | -2,067 | -14,041 | -23,559 | -8,671 |
| Net Income | $-8,212 | $-2,067 | $-14,041 | $-23,559 | $-8,671 |
| EPS Basic Total Ops | -14.58 | -3.50 | -24.06 | -43.46 | -15.75 |
| EPS Basic Continuous Ops | -14.59 | -3.50 | -24.02 | -42.91 | -15.74 |
| EPS Diluted Total Ops | -14.58 | -3.50 | -24.06 | -43.46 | -15.75 |
| EPS Diluted Continuous Ops | -14.59 | -3.50 | -24.02 | -42.91 | -15.74 |
| EPS Diluted Before Non-Recurring Items | N/A | -3.50 | -24.06 | -42.86 | -15.79 |
| EBITDA(a) | $-8,226 | $-2,685 | $-14,486 | $-24,065 | $-9,398 |